Thanks to the support of Healthware Group as global co-host and main sponsor, and to the conference chairman, Roberto Ascione, Frontiers Health is recognised as one of the leading global health innovation events and has become the epicentre of the digital health ecosystem.

The conference agenda, in its second year as a hybrid physical-virtual experience, will feature partnership opportunities to run custom breakout sessions, corporate events, keynote speakers, discussion panels, plenary sessions, challenges, breakout sessions and more.

Themes

This year’s conference will explore topics inspired by healthcare, including:

Digital Therapeutics
Patent protections, regulatory developments, reimbursement strategies, data protection, open-sourcing healthcare

Digital Transformation
R&D transformation, health insurance trends, consumerization of healthcare, mjedical on-demand models, the connected patient

Telehealth
Patient centricity, remote monitoring, beyond episodic care, mental telehealth, big data & AI

Funding & Scaling
SPAC strategies, digital health IPOs, investments

Tickets

Take advantage of the Early Bird discount to get your ticket – digital or in-person – to attend the most important global event dedicated to digital health innovation!

Buy your pass to keep up to date with the global conference

MSD has announced the first Europe-wide Patient Digital Health Awards (PDHA.eu), a competition intended to directly involve patients and patient advocacy associations so as to highlight their needs and diverse experiences as drivers of digital health thinking.

Modeled after the highly successful Italian edition now in its fourth year, PDHA.eu 2021 was developed in collaboration with Digital Health Academy to inspire and recognize digital healthcare innovation from a patient perspective. It applauds solutions aimed at improving care and quality of life for patients and their caregivers, particularly those developed collaboratively with patients and/or advocacy organizations.

The competition is open to individuals, patient associations, healthcare providers, scientific foundations, public or private universities and educational institutions, services companies, IT companies, and startups that are located within any of the EU Member States, EFTA Members, the Balkans, and the UK.

Applications must be submitted by 25 July 2021, 12:00 am CET.

The award categories are: Digital Prevention and Diagnostics, Mental Health, and Social Support, New Ways to Interact with Healthcare Teams and Providers, Disease Monitoring and Therapeutics, and Returning to Care (post-pandemic).

More than merely an award, the PDHA.eu initiative bolsters the vital role of healthcare innovation at the rapidly evolving intersection of technology and science, for both patients and providers.

PDHA.eu’s commitment to putting patients first, from the project themes to the judging panel members, truly sets it apart, as do its goals of sparking innovation, connecting patients and innovators, and creating a positive synergy within the communities.

For more information and to enter the competition, visit www.pdha.eu today!

This year, Frontiers has been a global Hybrid conference. In line with the “new normal” situation, the format of the 2020 edition has been hybrid, combining online global streaming together with offline events and activities held at hubs in multiple locations such as Italy, Germany, Finland, Spain, the USA, Switzerland and more.

It has been dedicated to digital health innovation in the context of the “new normal”, focusing on telemedicine, digital therapies, breakthrough technologies, patient-centricity, healthcare transformation and ecosystem development.

You can read the full live coverage on the pharmaphorum dedicated pages: Day 1 – Day 2

Yes, you read it right.

Frontiers Health is changing format, combining online and offline events and different activities in Italy, Germany, Finland, Spain, USA and many other locations.

Join us on the 12^th and 13^th of November

The Frontiers Health Global conference will go live in a new hybrid and engaging format, which has already proven effective with the Frontiers Health Live event held in May.
In fact, 7 hours of live coverage reached over 20,000 users worldwide.

The local hubs will host the iconic breakouts and plenary sessions. So attendees from all over the world will enjoy the pure Frontiers Health conference spirit, on line and also offline.

In fact, they could take advantage of the “silent conference” experience, designed for off line attendees.

Don’t miss the Start-up Discovery and the networking opportunities in dedicated virtual rooms.

Get your ticket now

Open Accelerator is looking for innovative, high-tech projects and startups leveraging digital technologies to improve patients’ lives.

The best proposals will take part in the acceleration program with the possibility of receiving a seed investment of up to € 100,000 per project.

The 2020 Call for Solutions

The 2020 Call for Solutions is preferably targeted at the therapeutic areas of the Central Nervous System and Respiratory, with a particular focus on the 4 technological macro areas: Digital Prevention, Monitoring and Therapeutics; Digital Diagnostics; Virtual Health; Clinical Trials Digitalization.

This year, in an attempt to transform the COVID-19 emergency into a growth opportunity for the healthcare system, ZCube is also presenting the Special Challenge concerning new ways of interaction among healthcare professionals, Industry and the community.

Open Accelerator is continuing with conviction into its fourth edition, reaffirming its commitment to supporting young startups, helping  to transform promising projects into concrete solutions for patients – comments Elena Zambon, President of Zambon Spa and creator of the accelerator programme – “Digital solutions have never been such a vital support for patients and caregivers as they have at this time. We have direct experience of this through ParkinsonCare, our telenursing service with a human touch. That is why we have decided to dedicate the 2020 Call to digital initiatives. We are convinced that they will be increasingly important in tackling the challenges that lie ahead in terms of health and the system’s sustainability. This programme is yet another way in which we are pursuing with conviction our commitment to improving patients’ lives, integrating cure and care with a multidisciplinary approach.

After the closure of the Call, on the 20^th of July, the Open Accelerator team in collaboration with a panel of experts will select the startups which between October and November will participate in the intensive 4-week acceleration programme, consisting of tailored online and onsite sessions held in the OpenZone scientific campus just outside Milan.

The Open Accelerator programme

By taking part in the Open Accelerator programme, the startups will have access to a vast international network of entrepreneurs, scientists, investors, Venture capitalists and Life Sciences professionals. At the end of the programme the most promising projects will be awarded a seed investment of up to € 100,000. Finally, any possible synergies with the companies of the Zambon Group will be assessed.

Open Accelerator 2020 Call is one of a kind both- for its focus on digital health technologies and for its pragmatic approach, strongly focused on identifying concrete proposals for delivering solutions to healthcare needs – says Fabrizio Conicella, General Manager and Board Member of OpenZone and Zcube – It is only through the active engagement of existing and prospective partnerships that we will be able to maximize the potential of the proposals we receive and select with a clear objective: to offer to the market innovative solutions that currently don’t exist.

The initiative also leverages the support of several partners, including Deloitte, Unicredit Start Lab, Premio Marzotto, IQVIA Biotech, Italian Angels for Biotech, Portolano & Cavallo, Bird&Bird, Innogest, Evoleen, HUMA, NINA Capital, and Lifeseeder. Discussions are currently underway with other potential Italian and international partners.

Ferrer is a global medium-sized pharmaceutical company headquartered out of Barcelona with a presence in over 110 countries.

The vision is to enable more personalized, effective and responsive care to patients through a connected ecosystem facilitated by digital technologies.

Gemma Estrada, Director of Digital Health in Ferrer comments: We understand that in order to generate and implement patient-driven solutions using digital technologies successfully and sustainably, we need to balance the knowledge and experience of pharma companies with the creativity and agility of start-ups.

Ferrer4Future is all about that!

Through Ferrer4Future program, start-ups are invited to respond to 3 meaningful challenges:

• Enhance care for chronic patients (ie. Pulmonary Arterial Hypertension)
• Improve patient engagement and adherence (ie. in the field of cardio-metabolism)
• Reduce Chronic Pain.

The first batch of challenges were launched at the beginning of October and the application period will remain open until the 20^th of December 2019 at noon. Nevertheless, there will be an on-going screening of the applications in order to guarantee swift feedback to the participating start-ups.

If the solution proposed by the start-up is a “match” with Ferrer’s interests, Ferrer will either partner with the start-up right away or enroll the start-up in the mentoring program, depending on the maturity of the solution proposed.

The program offered is not only bespoke but also personalized for each startup. The duration is flexible between 6 & 18 months during which access is guaranteed to Ferrer mentors, to experts from the various business units, and to internal resources for piloting and developing the solution further.

• The company is launching a call for innovation for early-stage start-ups focused on developing digital health services and solutions to tackle some of the present and future dermatological challenges
• The call was launched at the first Barcelona Health Hub Summit, a gathering to foster the relationships among big companies, start-ups and investors with an eye on digital health
• Start-ups can apply at almiralldigitalgarden.com starting today. Almirall will make a shortlist of 10 that will pitch their projects the 14th of November at Frontiers Health, a global event on health innovation
• The five selected projects will be invited to a nine-month acceleration program at the Barcelona Health Hub headquarters and up to a €50k grant, as well as expert mentorship from Almirall

Almirall, S.A. (ALM) has launched its first call for innovation to start-ups focused on dermatology digital health. This initiative is the first step in the creation of an accelerator programme called the Digital Garden, powered by Almirall and strengthens the company’s commitment to digital innovation based on developing services and solutions to tackle some of the present and future dermatological challenges. The call has been presented during the first Barcelona Health Hub (BHH) Summit, sponsored by Almirall, which has taken place at BHH’s headquarters, located in Barcelona, Spain.

The Digital Garden will begin its journey supporting up to five start-ups chosen after a selection process that will end on November 14^th at Almirall’s event in Berlin at Frontiers Health 2019, a leading global event on digital health innovation of which Almirall is a sponsor.

Francesca Wuttke, Chief Digital Officer of Almirall, explained the importance of this project

I am so pleased and excited to announce the launch of the Digital Garden powered by Almirall, and to do so at the BHH Summit. In fact, the five start-ups selected during Frontiers of Health will have access to a nine-month acceleration program based in the BHH headquarters, among other important benefits.

Digital Garden’s selection process

Interested start-ups can apply at almiralldigitalgarden.com, where they will also find the program’s inclusion criteria and offerings. Following a review of the applicants, Almirall will make a shortlist of 10 companies that will be invited to Frontiers Health 2019 to pitch their business models at an Almirall sponsored event that will take place on Thursday 14^th of November. The five winning project teams will begin a nine-month acceleration program in January at the BHH headquarters, with the goal of graduating them into venture capital funding. The program will include introductions to investors as well as an investor day.

In addition to the acceleration program, the five chosen start-ups will receive a number of key incentives, including up to a €50K grant that is determined based on a bespoke gap analysis of the start-up and achievement of certain milestones. In addition, they will receive mentoring from top pharma industry experts from all specialties and program stages; and will have the opportunity to leverage leading hospitals in Barcelona as a test bed for digital pilots, with potential access to HCPs and patients; the potential to collaborate on actual Almirall projects; and have access to Almirall’s communication and PR networks to promote their projects, among others.

“Embracing technologies to better access data to empower patients”

Francesca Wuttke is one of the four BHH Ambassadors, highly renowned professionals in digital health that are dedicated and aligned with the goals of the Barcelona Health Hub. They are collaborating to increase awareness in digital health and in a global recognition of the BHH. During the BHH Summit 2019, she moderated one of the panels entitled “Embracing technology to better access data to empower patients”. CEOs from three of the start-ups that are sharing BHH co-working space have discussed growing trends in the pharmaceutical industry.
Increasingly, pharma companies are collaborating with start-ups to improve the strength of their data and bring efficiencies with regard to time and cost. The panellists have also shared their views about the potential of new technologies in the era of Real World Data and Real World Evidence, the impact of regulation and the future of partnerships between big companies and start-ups with its implicit challenges and lessons learned.

According to Francesca Wuttke,

Medical dermatology is a representative example of the potential of patient centric digital health. The Digital Garden, powered by Almirall can be seen as a case study of both the recent and rapid development in this space and the huge potential of this new digital revolution in medicine.